Literature DB >> 1062801

Hemoglobin Wayne: a frameshift mutation detected in human hemoglobin alpha chains.

M Seid-Akhavan, W P Winter, R K Abramson, D L Rucknagel.   

Abstract

Hemoglobin Wayne is an alpha chain variant which manifests itself as two minor hemoglobin (Hb) components that migrate more rapidly than Hb A on electrophoresis at pH 8.6. It has been found in a child with Fanconi's anemia and in three generations of the child's family. Each of the minor components yields an alpha chain in which the carboxyl-terminal tripeptide sequence, Lys-Tyr-Arg, has been replaced by the octapeptide sequence Asx-Thr-Val-Lys-Leu-Glu-Pro-Arg. In alpha Wayne I, the slower of the pair, Asx is asparagine, whereas in alpha Wayne II it is aspartic acid. Comparison of the alpha Wayne sequences with the amino-acid sequences of alpha A and alpha Constant Spring leads to the conclusion that Hb Wayne I is the result of a -1 frameshift mutation in the alpha chain and that Hb Wayne II is formed secondarily by spontaneous deamidation of the new asparagine residue. A frameshift is consistent with a single mRNA base sequence for the last eight codons involved and supports the view of Clegg, Weatherall, and Milner [Nature (1971) 234, 337-341] that Hb Constant Spring is the result of a terminator mutation leading to translation of 31 codons not normally translated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1062801      PMCID: PMC336023          DOI: 10.1073/pnas.73.3.882

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Hemoglobin Koya Dora: high frequency of a chain termination mutant.

Authors:  W W De Jong; P Meera Khan; L F Bernini
Journal:  Am J Hum Genet       Date:  1975-01       Impact factor: 11.025

Review 2.  Human hemoglobin stability and instability: molecular mechanisms and some clinical correlations.

Authors:  R F Rieder
Journal:  Semin Hematol       Date:  1974-10       Impact factor: 3.851

3.  An intercistronic region in the histidine operon of Salmonella typhimurium.

Authors:  M M Rechler; C B Bruni; R G Martin; W Terry
Journal:  J Mol Biol       Date:  1972-08-28       Impact factor: 5.469

4.  Nucleotide sequences of human globin messenger RNA.

Authors:  B G Forget; C A Marotta; S M Weissman; I M Verma; R P McCaffrey; D Baltimore
Journal:  Ann N Y Acad Sci       Date:  1974-11-29       Impact factor: 5.691

Review 5.  Denaturation of the normal and abnormal hemoglobin molecule.

Authors:  E A Rachmilewitz
Journal:  Semin Hematol       Date:  1974-10       Impact factor: 3.851

6.  Haemoglobin Icaria, a new chain-termination mutant with causes alpha thalassaemia.

Authors:  J B Clegg; D J Weatherall; I Contopolou-Griva; K Caroutsos; P Poungouras; H Tsevrenis
Journal:  Nature       Date:  1974-09-20       Impact factor: 49.962

7.  Haemoglobin Tak: a variant with additional residues at the end of the beta-chains.

Authors:  G Flatz; J L Kinderlerer; J V Kilmartin; H Lehmann
Journal:  Lancet       Date:  1971-04-10       Impact factor: 79.321

8.  Sequence dependent deamidation rates for model peptides of hen egg-white lysozyme.

Authors:  A B Robinson; S Tedro
Journal:  Int J Pept Protein Res       Date:  1973

9.  Unexpectedly large size of globin messenger ribonucleic acid.

Authors:  P Gaskill; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1971-01       Impact factor: 11.205

10.  Evolution and the distribution of glutaminyl and asparaginyl residues in proteins.

Authors:  A B Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

View more
  10 in total

1.  Nucleotide sequence of 3' untranslated portion of human alpha globin mRNA.

Authors:  J T Wilson; J K deRiel; B G Forget; C A Marotta; S M Weissman
Journal:  Nucleic Acids Res       Date:  1977-07       Impact factor: 16.971

Review 2.  The thalassemias: molecular mechanisms of human genetic disease.

Authors:  R A Spritz; B G Forget
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

3.  Prediction of protein deamidation rates from primary and three-dimensional structure.

Authors:  N E Robinson; A B Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

4.  Locus assignment of alpha-globin structural mutations by hybrid-selected translation.

Authors:  S A Liebhaber; F E Cash
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

5.  Hemoglobin Wayne causing a falsely elevated hemoglobin A1c.

Authors:  Alexis Bejcek; David Wenkert
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-10-15

6.  Alarming increase in HbA1c and near misdiagnosis of diabetes mellitus resulting from a clinical laboratory instrument upgrade and haemoglobin variant.

Authors:  Steven D Chessler; Donald E Lee
Journal:  BMJ Case Rep       Date:  2018-06-14

7.  Chronic hemolytic anemia due to novel alpha-globin chain variants: critical location of the mutation within the gene sequence for a dominant effect.

Authors:  Claude Préhu; Kamran Moradkhani; Jean Riou; Michel Bahuau; Pierre Launay; Natacha Martin; Henri Wajcman; Michel Goossens; Frédéric Galactéros
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

8.  Development of a somatic mutation screening system using Hb mutants. IV. Successful detection of red cells containing the human frameshift mutants Hb Wayne and Hb Cranston using monospecific fluorescent antibodies.

Authors:  G Stamatoyannopoulos; P E Nute; T Papayannopoulou; T McGuire; G Lim; H F Bunn; D Rucknagel
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

9.  HEMOGLOBIN WAYNE VARIANT INTERFERING WITH HEMOGLOBIN A1C MEASUREMENT.

Authors:  Maali Milhem; Mose July; Shahed Elhamdani; Nesreen BenHamed
Journal:  AACE Clin Case Rep       Date:  2019-01-30

10.  Led Astray by Hemoglobin A1c: A Case of Misdiagnosis of Diabetes by Falsely Elevated Hemoglobin A1c.

Authors:  Jean Chen; Amy Diesburg-Stanwood; Geza Bodor; Neda Rasouli
Journal:  J Investig Med High Impact Case Rep       Date:  2016-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.